- Home
- / Itamar Medical
Itamar Medical
Stock Price
₪3.2
2021-11-10
Market Capitalization
₪155.6 B
2021-11-10
Revenue
$41 M
FY, 2020
Itamar Medical Summary
Company Summary
- Overview
- Itamar Medical is a medical device company providing solutions to help diagnose sleep apnea and heart conditions. It develops WatchPAT, a product used for the diagnosis of sleep breathing disorders in the home environment.
- Type
- Public
- Status
- Active
- Founded
- 1997
- HQ
- Caesarea, IL | view all locations
- Cybersecurity rating
Table of Contents
Key People
Dan Shlezak, Vice President, Operations and Engineering
Iira Prigat, President, Japan & China
Jeff Schmidt, Senior VP, Sales, North America
Operating MetricsView all
Patents Issued
62
47.9%
FY, 2019
Patents Pending
11
15.4%
FY, 2019
LocationsView all
3 locations detected
Caesarea, Haifa District HQ
Israel
Khalamish St 9
Atlanta, GA
United States
3290 Cumberland Club Drive #100
Amsterdam, NH
Netherlands
Krijn Taconiskade 430
Itamar Medical Financials
Summary Financials
- Revenue (Q3, 2021)
- $13.6M
- Gross profit (Q3, 2021)
- $10.1M
- Net income (Q3, 2021)
- ($8.0M)
- Cash (Q3, 2021)
- $10.7M
- EBIT (Q3, 2021)
- ($7.3M)
- Enterprise value
- $155.6B